|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-4
|
|
pubmed:abstractText |
This prospective study examines the changes in short-term intraocular pressure (IOP) in patients with wet age-related macular degeneration (AMD) receiving intravitreal injections of 0.05 mL ranibizumab (Lucentis) in a supine position.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1120-6721
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
174-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19927267-Aged,
pubmed-meshheading:19927267-Aged, 80 and over,
pubmed-meshheading:19927267-Angiogenesis Inhibitors,
pubmed-meshheading:19927267-Antibodies, Monoclonal,
pubmed-meshheading:19927267-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:19927267-Female,
pubmed-meshheading:19927267-Humans,
pubmed-meshheading:19927267-Injections,
pubmed-meshheading:19927267-Intraocular Pressure,
pubmed-meshheading:19927267-Male,
pubmed-meshheading:19927267-Middle Aged,
pubmed-meshheading:19927267-Prospective Studies,
pubmed-meshheading:19927267-Supine Position,
pubmed-meshheading:19927267-Tonometry, Ocular,
pubmed-meshheading:19927267-Vascular Endothelial Growth Factor A,
pubmed-meshheading:19927267-Vitreous Body,
pubmed-meshheading:19927267-Wet Macular Degeneration
|
|
pubmed:articleTitle |
Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis).
|
|
pubmed:affiliation |
Department of Ophthalmology, Ludwigshafen Hospital, Germany.
|
|
pubmed:publicationType |
Journal Article
|
